We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

162 hedge funds and large institutions have $867M invested in Ariad Pharmaceuticals Inc in 2016 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 45 increasing their positions, 64 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more call options, than puts

Call options by funds: $7.3M | Put options by funds: $3.77M

7% more capital invested

Capital invested by funds: $812M → $867M (+$54.8M)

6% less funds holding

Funds holding: 172 → 162 (-10)

24% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 29

30% less repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 64

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
162
Holders Change
-10
Holders Change %
-5.81%
% of All Funds
4.32%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
22
Increased
45
Reduced
64
Closed
29
Calls
$7.3M
Puts
$3.77M
Net Calls
+$3.53M
Net Calls Change
-$522K

Top Buyers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
+$31.3M
2
PI
Putnam Investments
Massachusetts
+$14.9M
3
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$9.03M
4
TA
Tamarack Advisers
California
+$8.97M
5
JIM
Jupiter Investment Management
United Kingdom
+$6.86M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$15.8M
2
State Street
State Street
Massachusetts
-$6.68M
3
AIMCA
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
-$6.11M
4
BNP Paribas Asset Management
BNP Paribas Asset Management
France
-$5.94M
5
UBS Group
UBS Group
Switzerland
-$2.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$5.48M -$65K -11,589 -1%
HS
27
HighVista Strategies
Massachusetts
$5.16M – – –
Deutsche Bank
28
Deutsche Bank
Germany
$5.06M +$2.94M +523,830 +195%
HI
29
HBK Investments
Texas
$4.98M -$301K -53,651 -6%
CA
30
Commerzbank Aktiengesellschaft
Germany
$4.02M +$3.39M +605,067 +2,532%
PP
31
PDT Partners
New York
$3.95M +$1.14M +202,700 +49%
RPAM
32
Rhenman & Partners Asset Management
Sweden
$3.83M +$953K +170,000 +40%
Goldman Sachs
33
Goldman Sachs
New York
$3.77M +$1.16M +206,616 +54%
BIM
34
BlackRock Investment Management
Delaware
$3.76M +$139K +24,858 +4%
TCIM
35
TIAA CREF Investment Management
New York
$3.58M -$563K -100,370 -15%
Charles Schwab
36
Charles Schwab
California
$3.57M -$117K -20,835 -4%
Renaissance Technologies
37
Renaissance Technologies
New York
$3.18M -$1.57M -279,497 -36%
BG
38
Bellevue Group
Switzerland
$3.16M +$2.77M +495,000 New
GC
39
Guggenheim Capital
Illinois
$2.42M -$1.22M -217,880 -37%
RA
40
Royce & Associates
New York
$2.4M – – –
JGC
41
J. Goldman & Co
New York
$2.38M +$2.08M +371,700 New
California Public Employees Retirement System
42
California Public Employees Retirement System
California
$2.33M -$123K -21,900 -6%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$2.27M +$255K +45,443 +15%
AllianceBernstein
44
AllianceBernstein
Tennessee
$2.19M +$182K +32,400 +10%
AIMCA
45
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$2.1M -$6.11M -1,090,246 -77%
IIM
46
Ironwood Investment Management
Massachusetts
$2.07M -$823K -146,880 -31%
JP Morgan Chase
47
JP Morgan Chase
New York
$1.97M -$26K -4,635 -1%
Ameriprise
48
Ameriprise
Minnesota
$1.96M -$368K -65,663 -18%
TA
49
Teachers Advisors
New York
$1.95M – – –
Millennium Management
50
Millennium Management
New York
$1.87M +$87.4K +15,598 +6%
1
2
3 4 5

ARIA Hedge Fund Activity: Q1 2016 in Review

162 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q1 2016, worth a combined $867M — up 6.8% from $812M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of ARIA and 22 opened new positions — a net loss of 7 holders — while 64 trimmed existing stakes and 45 added.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $31.3M. The largest seller was Fidelity Investments, cutting an estimated $15.8M.

  • 162 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q1 2016, down from 172 in Q4 2015.
  • Funds reported $867M of Ariad Pharmaceuticals Inc stock for Q1 2016, up 6.8% quarter-over-quarter.
  • 22 funds opened new Ariad Pharmaceuticals Inc positions in Q1 2016 and 29 closed out, a net change of -7 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q1 2016 was Consonance Capital Management, an estimated $31.3M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q1 2016 was Fidelity Investments, an estimated $15.8M sold.

Based on aggregated 13F filings for Q1 2016.